Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants

Clinical Transplantation

Volumn 14, Issue 3, 2000, Pages 212-217

  Barama, A ^a   Oza, U ^d   Panek, R ^e   Belitsky, Philip ^b,c   MacDonald, A S ^b   Lawen, J ^b   McAlister, V ^b   Kiberd, B ^b  

^a FMC   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^d BOMBAY HOSPITAL   (India)

^e Bombay Hospital ^*

Author keywords

Graft outcome; Haploidentical; Kidney transplant; Live donor; Recipient sensitization

Indexed keywords

ANTIBODY; CYCLOSPORIN; PANEL REACTIVE ANTIBODY; PREDNISONE; UNCLASSIFIED DRUG;

ARTICLE; CREATININE BLOOD LEVEL; GRAFT REJECTION; HLA MATCHING; HOSPITALIZATION; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION;

ADULT; CYCLOSPORINE; FAMILY; FEMALE; GRAFT SURVIVAL; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE;

EID: 0034105843     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140306.x     Document Type: Article

References (16)

1. OPELZ G, TERASAKI PI. Histocompatibility matching utilizing responsiveness as a new dimension. Transplant Proc 1972: 4: 433.
2. TERASAKI PI, YUGE J, CECKA JM, GJERTSON DW, TAKEMOTO S, CHO Y. Thirty-yr trends in clinical kidney transplantation. In: Terasaki P, ed. Clinical Transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1993: 553.
3. FULLER TC, COSIMI AB, RUSSELL PS. Use of an antiglobuline-ATG reagent for detection of low levels of alloantibody - improvement of allograft survival in presensitized recipients. Transplant Proc 1978: 10: 463.
4. ZHOU YC, CECKA JM. Sensitization in renal transplantation. In: Terasaki P, ed. Clinical Transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1991: 313.
5. KNIGHT RJ, KERMAN RH, WELSH M et al. Chronic rejection in primary renal allograft recipients under cyclosporine prednisone immunosuppressive therapy. Transplantation 1991: 51: 355.
6. NICOL D, MACDONALD AS, LAWEN J, BELITSKY P. Early prediction of renal allograft loss beyond one yr. Transplant Int 1993: 6: 153.
7. ALARIF L, RODRIGUEZ R, BLACKBURN S, LIGHT JA. Influence of pretransplant antibodies one early renal allograft rejection. Transpl Proc 1987: 19: 771.
8. LAZDA VA. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch. Transplantation 1994: 57: 964.
9. MAHONNEY RJ, AULT KA, GIVEN SR et al. The flow cytometric crossmatch and early renal transplant loss. Transplantation 1990: 49: 527.
10. MARTIN S, LIGGETT H, ROBSON A et al. The association between a positive T and B cell flow cytometry crossmatch and renal transplant failure. Transpl Immunol 1993: 1: 270.
11. SHROYER TW, DEIERHOL MH, MINK CA et al. A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups. Transplantation 1995: 59: 626.
12. CHAPMAN JR, DEIERHOI MH, CARTUER NP et al. Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation. Transplant Proc 1985: 17: 2480.
13. OGURA K, TERASAKI PI, JOHNSON C et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993: 56: 294.
14. KERMAN RH, VAN BUREN CT, LEWIS RM et al. Improved graft survival for flow cytometry and antihuman globulin crossmatch negative retransplant recipients. Transplantation 1990: 49: 52.
15. KERMAN RH, KIMBALL PM, VAN BUREN CT et al. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival. Transplantation 1991: 51: 316.
16. FULLER TC, PHELAN D, GEBEL HM, RODEY GE. Antigenic specificity of antibody reactive in the antiglobulinaugmented lymphotoxicity test. Transplantation 1982: 34: 24.